All stock lists
bioAffinity Technologies, Inc. (NASDAQ:BIAF)
US · Delayed Price · Currency is USD
Healthcare · Medical - Diagnostics & Research
$1.74-$0.11 (-5.91%)
Market cap
$10.9M
Insider Score
Health Score
Analyst consensus
Listed since
Sep 1, 2022
Website
BIAF analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on BIAF that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering BIAF
No firm covering BIAF has a call old enough to have finished a 1Y holding period yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
